Do metoclopramide and ondansetrone alter mivacurium-induced neuromuscular blockade? - a randomised trial

Mehmet Tercan1, Esra Mercanoglu Efe1, Gurkan Turker1

  • 1Anesthesiology and Reanimation Department, Medical Faculty, Uludag University, Bursa, Turkey.

Abstract

Insights

Metoclopramide and ondansetrone significantly affect mivacurium neuromuscular blockade, with ondansetrone showing greater reliability. Both drugs altered plasma cholinesterase levels, impacting blockade recovery.

Area of Science:

  • Anesthesiology
  • Pharmacology

Background:

  • Investigating the impact of metoclopramide and ondansetrone on mivacurium-induced neuromuscular blockade.
  • Assessing the influence of these agents on neuromuscular blockade characteristics.

Purpose of the Study:

  • To compare the effects of metoclopramide and ondansetrone on mivacurium neuromuscular blockade.
  • To evaluate the impact on onset time, recovery indices, and plasma cholinesterase levels.

Main Methods:

  • A randomized study involving 75 patients receiving metoclopramide, ondansetrone, or normal saline before mivacurium administration.
  • Monitoring neuromuscular blockade parameters (onset time, T25, T75, T90) and plasma cholinesterase levels.

Main Results:

  • Metoclopramide shortened onset time most significantly, followed by ondansetrone compared to saline.
  • Both metoclopramide and ondansetrone improved recovery indices compared to saline.
  • Metoclopramide demonstrated superior efficacy over ondansetrone in enhancing emergence indices.

Conclusions:

  • Ondansetrone is considered more reliable than metoclopramide when co-administered with mivacurium.
  • Both drugs significantly reduced plasma cholinesterase levels, affecting neuromuscular blockade.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
927
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
3.6K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
1.3K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
2.0K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
1.1K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics01:11

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
991